Biological versus mechanical valves in the mitral position

Y. Shimoyama, Y. Wanibuchi, T. Ino, Y. Terada, H. Takagi, S. Furuta, Y. Soma, R. Yozu, Hideyuki Shimizu, T. Inoue

Research output: Contribution to journalArticle

Abstract

The long-term late results of isolated mitral valve replacement before April 1981 were retrospectively evaluated in 54 patients receiving a Hancock valve (HX) with a total follow-up of 424 patient-years (py) and 37 patients receiving a Björk-Shiley valve (BS) with a total follow-up of 366 py. There was no significant difference in regard to preoperative age, cardiothoracic ratio, electrocardiogram, or New York Heart Association functional class between the two groups. All of the BS group and 43 of the HX patients received long-term anticoagulant therapy. No significant difference was notable between the two groups in hospital mortality. Actuarial survival rate excluding hospital deaths was 75.5 +/- 6.7% for the HX group, and 80.8 +/- 7.1% for the BS group at ten years (not significant). There was no significant difference between the two groups in overall incidence of thromboembolism (HX 1.4% py, BS 1.9% py), anticoagulant related bleeding (HX 0.5% py, BS 0.8% py), or endocarditis (HX 0.5% py, BS 0.3% py). Actuarial freedom from reoperation at ten years was 69.6 +/- 8.1% for the HX group, and 93.5 +/- 4.4% for the BS group (p less than 0.01). Event free survival excluding hospital deaths at ten years was 49.2 +/- 8.1% for the HX group, 70.6 +/- 8.3% for the BS group (p less than 0.05). We prefer a mechanical prosthesis except in patients over 65 years old, who have a short life expectancy, in whom anticoagulation is thought to be difficult, and who hope a biological valve.

Original languageEnglish
Pages (from-to)806-810
Number of pages5
JournalKyobu geka. The Japanese journal of thoracic surgery
Volume42
Issue number10
Publication statusPublished - 1989 Sep
Externally publishedYes

Fingerprint

Mitral Valve
Anticoagulants
Thromboembolism
Hospital Mortality
Life Expectancy
Endocarditis
Reoperation
Disease-Free Survival
Prostheses and Implants
Electrocardiography
Survival Rate
Hemorrhage

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Shimoyama, Y., Wanibuchi, Y., Ino, T., Terada, Y., Takagi, H., Furuta, S., ... Inoue, T. (1989). Biological versus mechanical valves in the mitral position. Kyobu geka. The Japanese journal of thoracic surgery, 42(10), 806-810.

Biological versus mechanical valves in the mitral position. / Shimoyama, Y.; Wanibuchi, Y.; Ino, T.; Terada, Y.; Takagi, H.; Furuta, S.; Soma, Y.; Yozu, R.; Shimizu, Hideyuki; Inoue, T.

In: Kyobu geka. The Japanese journal of thoracic surgery, Vol. 42, No. 10, 09.1989, p. 806-810.

Research output: Contribution to journalArticle

Shimoyama, Y, Wanibuchi, Y, Ino, T, Terada, Y, Takagi, H, Furuta, S, Soma, Y, Yozu, R, Shimizu, H & Inoue, T 1989, 'Biological versus mechanical valves in the mitral position', Kyobu geka. The Japanese journal of thoracic surgery, vol. 42, no. 10, pp. 806-810.
Shimoyama Y, Wanibuchi Y, Ino T, Terada Y, Takagi H, Furuta S et al. Biological versus mechanical valves in the mitral position. Kyobu geka. The Japanese journal of thoracic surgery. 1989 Sep;42(10):806-810.
Shimoyama, Y. ; Wanibuchi, Y. ; Ino, T. ; Terada, Y. ; Takagi, H. ; Furuta, S. ; Soma, Y. ; Yozu, R. ; Shimizu, Hideyuki ; Inoue, T. / Biological versus mechanical valves in the mitral position. In: Kyobu geka. The Japanese journal of thoracic surgery. 1989 ; Vol. 42, No. 10. pp. 806-810.
@article{78006f868c834eb8896dbd53ea0749b3,
title = "Biological versus mechanical valves in the mitral position",
abstract = "The long-term late results of isolated mitral valve replacement before April 1981 were retrospectively evaluated in 54 patients receiving a Hancock valve (HX) with a total follow-up of 424 patient-years (py) and 37 patients receiving a Bj{\"o}rk-Shiley valve (BS) with a total follow-up of 366 py. There was no significant difference in regard to preoperative age, cardiothoracic ratio, electrocardiogram, or New York Heart Association functional class between the two groups. All of the BS group and 43 of the HX patients received long-term anticoagulant therapy. No significant difference was notable between the two groups in hospital mortality. Actuarial survival rate excluding hospital deaths was 75.5 +/- 6.7{\%} for the HX group, and 80.8 +/- 7.1{\%} for the BS group at ten years (not significant). There was no significant difference between the two groups in overall incidence of thromboembolism (HX 1.4{\%} py, BS 1.9{\%} py), anticoagulant related bleeding (HX 0.5{\%} py, BS 0.8{\%} py), or endocarditis (HX 0.5{\%} py, BS 0.3{\%} py). Actuarial freedom from reoperation at ten years was 69.6 +/- 8.1{\%} for the HX group, and 93.5 +/- 4.4{\%} for the BS group (p less than 0.01). Event free survival excluding hospital deaths at ten years was 49.2 +/- 8.1{\%} for the HX group, 70.6 +/- 8.3{\%} for the BS group (p less than 0.05). We prefer a mechanical prosthesis except in patients over 65 years old, who have a short life expectancy, in whom anticoagulation is thought to be difficult, and who hope a biological valve.",
author = "Y. Shimoyama and Y. Wanibuchi and T. Ino and Y. Terada and H. Takagi and S. Furuta and Y. Soma and R. Yozu and Hideyuki Shimizu and T. Inoue",
year = "1989",
month = "9",
language = "English",
volume = "42",
pages = "806--810",
journal = "Japanese Journal of Thoracic Surgery",
issn = "0021-5252",
publisher = "Nankodo Co., Ltd.",
number = "10",

}

TY - JOUR

T1 - Biological versus mechanical valves in the mitral position

AU - Shimoyama, Y.

AU - Wanibuchi, Y.

AU - Ino, T.

AU - Terada, Y.

AU - Takagi, H.

AU - Furuta, S.

AU - Soma, Y.

AU - Yozu, R.

AU - Shimizu, Hideyuki

AU - Inoue, T.

PY - 1989/9

Y1 - 1989/9

N2 - The long-term late results of isolated mitral valve replacement before April 1981 were retrospectively evaluated in 54 patients receiving a Hancock valve (HX) with a total follow-up of 424 patient-years (py) and 37 patients receiving a Björk-Shiley valve (BS) with a total follow-up of 366 py. There was no significant difference in regard to preoperative age, cardiothoracic ratio, electrocardiogram, or New York Heart Association functional class between the two groups. All of the BS group and 43 of the HX patients received long-term anticoagulant therapy. No significant difference was notable between the two groups in hospital mortality. Actuarial survival rate excluding hospital deaths was 75.5 +/- 6.7% for the HX group, and 80.8 +/- 7.1% for the BS group at ten years (not significant). There was no significant difference between the two groups in overall incidence of thromboembolism (HX 1.4% py, BS 1.9% py), anticoagulant related bleeding (HX 0.5% py, BS 0.8% py), or endocarditis (HX 0.5% py, BS 0.3% py). Actuarial freedom from reoperation at ten years was 69.6 +/- 8.1% for the HX group, and 93.5 +/- 4.4% for the BS group (p less than 0.01). Event free survival excluding hospital deaths at ten years was 49.2 +/- 8.1% for the HX group, 70.6 +/- 8.3% for the BS group (p less than 0.05). We prefer a mechanical prosthesis except in patients over 65 years old, who have a short life expectancy, in whom anticoagulation is thought to be difficult, and who hope a biological valve.

AB - The long-term late results of isolated mitral valve replacement before April 1981 were retrospectively evaluated in 54 patients receiving a Hancock valve (HX) with a total follow-up of 424 patient-years (py) and 37 patients receiving a Björk-Shiley valve (BS) with a total follow-up of 366 py. There was no significant difference in regard to preoperative age, cardiothoracic ratio, electrocardiogram, or New York Heart Association functional class between the two groups. All of the BS group and 43 of the HX patients received long-term anticoagulant therapy. No significant difference was notable between the two groups in hospital mortality. Actuarial survival rate excluding hospital deaths was 75.5 +/- 6.7% for the HX group, and 80.8 +/- 7.1% for the BS group at ten years (not significant). There was no significant difference between the two groups in overall incidence of thromboembolism (HX 1.4% py, BS 1.9% py), anticoagulant related bleeding (HX 0.5% py, BS 0.8% py), or endocarditis (HX 0.5% py, BS 0.3% py). Actuarial freedom from reoperation at ten years was 69.6 +/- 8.1% for the HX group, and 93.5 +/- 4.4% for the BS group (p less than 0.01). Event free survival excluding hospital deaths at ten years was 49.2 +/- 8.1% for the HX group, 70.6 +/- 8.3% for the BS group (p less than 0.05). We prefer a mechanical prosthesis except in patients over 65 years old, who have a short life expectancy, in whom anticoagulation is thought to be difficult, and who hope a biological valve.

UR - http://www.scopus.com/inward/record.url?scp=0024722186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024722186&partnerID=8YFLogxK

M3 - Article

C2 - 2796070

AN - SCOPUS:0024722186

VL - 42

SP - 806

EP - 810

JO - Japanese Journal of Thoracic Surgery

JF - Japanese Journal of Thoracic Surgery

SN - 0021-5252

IS - 10

ER -